Dey Didn't Infringe Asthma Drug Patent, Fed. Circ. Rules
The Federal Circuit on Monday found in favor of generics maker Mylan Inc.'s Dey Pharma LP unit, upholding a lower court's judgment that it did not infringe a Sunovion Pharmaceuticals Inc....To view the full article, register now.
Already a subscriber? Click here to view full article